ILLUMINA, INC.
StreetZero Signal 72
About ILLUMINA, INC.
Illumina, Inc. is a public biotechnology company founded in 1998 and headquartered in San Diego, CA. It provides sequencing- and array-based solutions for genetic and genomic analysis across the Americas, Europe, Greater China, Asia Pacific, Middle East, and Africa. The company offers instruments and consumables for DNA sequencing and genotyping applications. It has been publicly traded on Nasdaq under ILMN since July 2000.
LATEST FUNDINGRule 144
$82.8M
Announced 2026-11-10
TOTAL RAISED$1.87B
IN THE NEWS
EMPLOYEES8625
FOUNDED1998
HQSan Diego, CA, United States
Industry
Public Equity (Nasdaq Stock Market)
Tags
BiotechnologyGenomicsPublic CompanySequencing
Key highlights
- Publicly traded on Nasdaq since 2000 with current market cap exceeding $35B.
- Operates in healthcare equipment and supplies with 8,625 employees.
- Offers sequencing instruments and consumables for genetic analysis globally.
- Historical venture backers include ARCH Venture Partners and Venrock.
- Rule 144 transaction of $82.8M executed with undisclosed investors.
Ask StreetZero about ILLUMINA, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (Nasdaq Stock Market) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account